 |
Bitterroot Bio
CEO Pavan Cheruvu
USA | Funding: $145M (+)
Website: https://brbio.com/
Bitterroot is harnessing the power of immunotherapy to develop and deliver transformative medicines for patients with cardiovascular disease
Website: https://brbio.com/
Bitterroot is harnessing the power of immunotherapy to develop and deliver transformative medicines for patients with cardiovascular disease
